MENU

VTGN VistaGen Therapeutics Forecast, Technical & Fundamental Analysis

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia... Show more

Industry: #Biotechnology
VTGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
VTGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

VTGN is expected to report earnings to rise 25.00% to -37 cents per share on November 05

VistaGen Therapeutics VTGN Stock Earnings Reports
Q3'26
Est.
$-0.37
Q2'26
Missed
by $0.05
Q4'25
Beat
by $0.28
Q3'25
Missed
by $0.01
Q2'25
Beat
by $0.14
The last earnings report on August 14 showed earnings per share of -30 cents, missing the estimate of -25 cents. With 3.02M shares outstanding, the current market capitalization sits at 13.09M.
A.I. Advisor
published General Information

General Information

a developer of embryonic stem cells for drug discovery and development

Industry Biotechnology

Industry
Biotechnology
Address
343 Allerton Avenue
Phone
+1 650 577-3600
Employees
41
Web
https://www.vistagen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COLD14.740.38
+2.65%
Americold Realty Trust
EDUC1.30N/A
N/A
Educational Development Corp
LAWR3.75N/A
N/A
Robot Consulting Co Ltd
TTWO201.44-1.54
-0.76%
Take-Two Interactive Software
ELVR41.43-1.40
-3.27%
Sayona Mining Limited

VTGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with MENS. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then MENS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-7.46%
MENS - VTGN
57%
Loosely correlated
-5.58%
UNCY - VTGN
43%
Loosely correlated
-2.39%
REPL - VTGN
38%
Loosely correlated
-1.90%
SYRE - VTGN
38%
Loosely correlated
-1.61%
KYTX - VTGN
38%
Loosely correlated
-2.58%
More
VistaGen Therapeutics (VTGN) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com